Journal
JOURNAL OF CONTROLLED RELEASE
Volume 240, Issue -, Pages 287-301Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2016.01.001
Keywords
Gene therapy; Gene delivery; Adeno-associated virus; AAV; Gene delivery vectors; Cancer
Funding
- Ford Foundation Fellowship
- National Science Foundation Graduate Fellowship
- UC Berkeley's Graduate Division Fellowships
- National Institutes of Health (NIH) [R01EY022975]
Ask authors/readers for more resources
Gene delivery vectors based on adeno-associated virus (AAV) have been utilized in a large number of gene therapy clinical trials, which have demonstrated their strong safety profile and increasingly their therapeutic efficacy for treating monogenic diseases. For cancer applications, AAV vectors have been harnessed for delivery of an extensive repertoire of transgenes to preclinical models and, more recently, clinical trials involving certain cancers. This review describes the applications of AAV vectors to cancer models and presents developments in vector engineering and payload design aimed at tailoring AAV vectors for transduction and treatment of cancer cells. We also discuss the current status of AAV clinical development in oncology and future directions for AAV in this field. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available